Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Central Nervous System Metastases: early-phase trial registry

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Central Nervous System Metastases: 2 US clinical trials tracked, none currently recruiting.

Central Nervous System Metastases is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Nancy Lin, MD, running 1 of these trials.

Enrollment posture brief

Registry condition central-nervous-system-metastases

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Central Nervous System M (th…0%
Open-enrollment share among volume-matched conditions near Central Nervous System Metastases

Central Nervous System Metastases has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Central Nervous System Metastases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Central Nervous System Metastases is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Central Nervous System Metastases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

hyperfractionated radiation therapy Radiation
1 trials
TRASTUZUMAB Drug
1 trials
PERTUZUMAB Drug
1 trials
ATEZOLIZUMAB Drug
1 trials
stereotactic radiosurgery Radiation
1 trials
laboratory biomarker analysis Other
1 trials

US sites by state

Facility locations filed on Central Nervous System Metastases trials. A trial with sites in several states counts in each.

Illinois 2 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Central Nervous System Metastases page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Central Nervous System Metastases trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Nancy Lin, MD sponsors the most Central Nervous System Metastases trials on record, review their full trial history before evaluating a specific study. See Nancy Lin, MD's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Central Nervous System Metastases condition card totals 2 registered trials; most-linked intervention hyperfractionated radiation therapy; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.